Department of Biochemistry, Albert Einstein College of Medicine, Yeshiva University, 1300 Morris Park Avenue, Bronx, New York 10461, United States.
Biochemistry. 2011 Feb 22;50(7):1247-54. doi: 10.1021/bi101642d. Epub 2011 Jan 25.
The PA3004 gene of Pseudomonas aeruginosa PAO1 was originally annotated as a 5'-methylthioadenosine phosphorylase (MTAP). However, the PA3004 encoded protein uses 5'-methylthioinosine (MTI) as a preferred substrate and represents the only known example of a specific MTI phosphorylase (MTIP). MTIP does not utilize 5'-methylthioadenosine (MTA). Inosine is a weak substrate with a k(cat)/K(m) value 290-fold less than MTI and is the second best substrate identified. The crystal structure of P. aeruginosa MTIP (PaMTIP) in complex with hypoxanthine was determined to 2.8 Å resolution and revealed a 3-fold symmetric homotrimer. The methylthioribose and phosphate binding regions of PaMTIP are similar to MTAPs, and the purine binding region is similar to that of purine nucleoside phosphorylases (PNPs). The catabolism of MTA in P. aeruginosa involves deamination to MTI and phosphorolysis to hypoxanthine (MTA → MTI → hypoxanthine). This pathway also exists in Plasmodium falciparum, where the purine nucleoside phosphorylase (PfPNP) acts on both inosine and MTI. Three tight-binding transition state analogue inhibitors of PaMTIP are identified with dissociation constants in the picomolar range. Inhibitor specificity suggests an early dissociative transition state for PaMTIP. Quorum sensing molecules are associated with MTA metabolism in bacterial pathogens suggesting PaMTIP as a potential therapeutic target.
铜绿假单胞菌 PAO1 的 PA3004 基因最初被注释为 5'-甲基硫腺苷磷酸化酶(MTAP)。然而,PA3004 编码的蛋白以 5'-甲基硫代次黄苷(MTI)为首选底物,代表了唯一已知的特异性 MTI 磷酸化酶(MTIP)。MTIP 不利用 5'-甲基硫代腺苷(MTA)。肌苷是一种弱底物,其 k(cat)/K(m) 值比 MTI 低 290 倍,是鉴定出的第二好的底物。铜绿假单胞菌 MTIP(PaMTIP)与次黄嘌呤复合物的晶体结构已解析至 2.8 Å 分辨率,揭示了一个 3 倍对称的同源三聚体。PaMTIP 的甲基硫代核糖和磷酸结合区域与 MTAPs 相似,嘌呤结合区域与嘌呤核苷磷酸化酶(PNPs)相似。铜绿假单胞菌中 MTA 的分解代谢涉及脱氨为 MTI 和磷酸解为次黄嘌呤(MTA→MTI→次黄嘌呤)。该途径也存在于疟原虫中,其中嘌呤核苷磷酸化酶(PfPNP)作用于肌苷和 MTI。鉴定出三种对 PaMTIP 具有紧密结合的过渡态类似物抑制剂,其解离常数在皮摩尔范围内。抑制剂特异性表明 PaMTIP 的过渡态早期解离。群体感应分子与细菌病原体中的 MTA 代谢有关,这表明 PaMTIP 是一个潜在的治疗靶点。